SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as retail traders speculate on potential government contracts following a congressional disclosure of stock purchases, sparking comparisons to $PLTR. The community is actively discussing chart patterns and a potential short squeeze, with bullish investors highlighting the company's AI-driven solutions and anticipating a breakout. Chatter revolves around potential gains amidst growing interest in AI for defense and security.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community discusses Elon Musk's recent $1 billion stock purchase, which many see as a sign of confidence and a potential catalyst for further gains. Community members are debating whether this is a bull trap or a genuine shift in momentum, with some pointing to technical indicators and others highlighting concerns about fundamentals. Overall, the focus is on how Musk's actions will impact the stock's trajectory amidst ongoing discussions about Tesla's future in AI and robotics.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW.X is gaining attention as the 'crow with knife' meme coin community rallies around its multichain functionality across $SOL.X, $CRO.X, and $ETH.X. The project's fully circulated supply, organic community growth, and burn mechanism are key talking points, with many expressing bullish sentiment and calling it the 'only option'.

Slopana

$SLOPANA.X is gaining traction as the self-proclaimed 'king of digital slop,' capitalizing on the meme coin frenzy within the Solana ecosystem. Community members highlight its strong community, CTO leadership and are actively encouraging others to join before a potential surge, referencing its availability on Phantom Wallet.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as its community, the Wolfpack, rallies around the project, drawing comparisons to the early days of Shiba Inu and Saitama. Community members express strong conviction, anticipating significant gains and highlighting the project's solid floor and dedicated development team. Talk centers around a potential breakout and the revival of the 'Inu season' within the crypto space.

The New York Times Co. is a media organization, which engages in creating, collecting, and distributing news and information. It offers news products and other interest-specific products, and related content and services. It offers newspapers, print, and digital products and investments. The firm also manages The New York Times, NYTimes.com, and mobile applications. The company was founded by Henry Jarvis Raymond and George Jones on September 18, 1851, and is headquartered in New York, NY.

New York Times Co. - Ordinary Shares - Class A

New York Times ($NYT) is trending due to Trump's recent announcement of a $15 billion defamation lawsuit against the publication, sparking community debate about potential impacts. Earnings and AI deals have also captured attention, with community members weighing the potential for growth through digital subscriptions and partnerships with companies like Amazon. Some traders are discussing ratings and price targets from analysts, as well as potential market plays.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors assess the likelihood of upcoming Fed rate cuts and their potential impact on the market, especially tech. Community discussions revolve around the possibility of a "sell the news" event following the Fed's decision, with some traders expressing concerns about an overextended market. Meanwhile, broader market strength and individual stock movements like NVIDIA's $6.3B deal continue to fuel the conversation.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

CNSP is trending as traders discuss a recent orphan drug designation transfer and speculate on potential catalysts, while others express skepticism due to the company's history of reverse splits and clinical trial setbacks. Community members are actively debating the stock's potential for a short squeeze versus the risk of further dilution. Some traders are focusing on the low float and cash position, while others are warning against the stock's long-term prospects.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster ($OUST) is trending due to its strategic partnership with Constellis, a major security firm, to integrate its lidar technology into global security operations, potentially opening a new $100B market. The community is excited about the potential for significant revenue growth and Ouster's role in physical AI. Broader discussions include the company's strong financial position, defense contracts, and expansion into smart city infrastructure, with some analysts predicting a continued upward trend.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire ($RDW) is trending amid a newly announced partnership with Honeywell to develop quantum-secure satellite communication systems. The community is focused on the potential of this collaboration, particularly its implications for the company's future earnings and potential for a short squeeze given high short interest. Some investors are also weighing in on a recent settlement related to accounting irregularities, while others express optimism about the space sector and RDW's long-term prospects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close.

NVST vs. ABT: Which Stock Should Value Investors Buy Now?

NVST vs. ABT: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights Broadcom, T-Mobile, Abbott Laboratories, CBL & Associates Properties and Crown Crafts

Zacks Analyst Blog spotlights Broadcom, T-Mobile, Abbott, CBL & Associates, and Crown Crafts with updates on growth, risks, and outlooks.

Top Research Reports for Broadcom, T-Mobile & Abbott

Broadcom, T-Mobile, and Abbott lead Zacks Research Daily with AI gains, 5G leadership, and strong medical device pipelines driving momentum.

MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G 

Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.

Hologic's Panther Fusion Signals More Molecular Diagnostics Upside

HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Investing in the Age of Longevity: Silver Economy Stocks in Focus

AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.

ABT Stock Gains From Navitor's Expanded Indication Approval in Europe

Abbott wins CE Mark in Europe for expanded Navitor use, boosting its Structural Heart business and lifting ABT stock.

ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?

As the structural heart market expands, Abbott and Edwards battle for leadership. Which stock holds stronger growth momentum now?

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ABT News

ABT Abbott Laboratories